This may explain why high DAPK1 expression strongly associates with the aggressive breast cancer phenotypes like the ER-negative breast cancers, especially the triple-negative breast cancers (TNBC) [26], which are the most aggressive, faster-growing, and highly metastatic [16, 27]. Here, DAPK1 is linked to triple-negative breast carcinoma.